KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Liabilities from Discontinued Operations (2023 - 2025)

Historic Liabilities from Discontinued Operations for Emergent BioSolutions (EBS) over the last 4 years, with Q3 2025 value amounting to $4.5 million.

  • Emergent BioSolutions' Liabilities from Discontinued Operations changed N/A to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year change of. This contributed to the annual value of $17.3 million for FY2015, which is N/A changed from last year.
  • Per Emergent BioSolutions' latest filing, its Liabilities from Discontinued Operations stood at $4.5 million for Q3 2025.
  • In the past 5 years, Emergent BioSolutions' Liabilities from Discontinued Operations registered a high of $37.5 million during Q1 2023, and its lowest value of $4.5 million during Q3 2025.
  • Moreover, its 3-year median value for Liabilities from Discontinued Operations was $4.8 million (2025), whereas its average is $12.3 million.
  • The largest annual percentage gain for Emergent BioSolutions' Liabilities from Discontinued Operations in the last 5 years was 5346.53% (2025), contrasted with its biggest fall of 5346.53% (2025).
  • Quarter analysis of 3 years shows Emergent BioSolutions' Liabilities from Discontinued Operations stood at $37.5 million in 2023, then crashed by 73.07% to $10.1 million in 2024, then plummeted by 55.45% to $4.5 million in 2025.
  • Its Liabilities from Discontinued Operations stands at $4.5 million for Q3 2025, versus $4.7 million for Q2 2025 and $4.8 million for Q1 2025.